glp 1 addiction Not just obesity: GLP-1 receptor agonists advance on Caron Pioneers Novel Use of
Description
Ondansetron for intravenous use: dose-dependent QT interval prolongation
Conclusions/interpretation In individuals with NAFLD and type 2 diabetes, GLP-1RAs are associated with lower incidences of adverse CVEs and all-cause mortality compared with metformin or other second- and third-line glucose-lowering medications
doi: 10.1080/10408391003699550
Thermal Allodynia: This involves sensitivity to mild temperature changes
However, like all medications, it comes with its own set of side effects
